Comments
Dr Reddy’s Laboratories Ltd announced today that it has launched Moxifloxacin Hydrochloride Tablets, 400 mg, a therapeutic equivalent generic version of Avelox (moxifloxacin HCl) tablets 400mg in the US market on Tuesday.
The product has been approved from the US Food and Drug Administration, a release from the Hyderabad-based pharma major said.
The Avelox tablets brand had US sales of approximately $195 million for the most recent 12 months ended in December 2013 according to IMS Health.
Dr Reddy’s Moxifloxacin Hydrochloride Tablets, 400 mg is available in bottle counts of 30.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.